× Industry Reports Services Press Release Contact us About us

Europe In-vitro Colorectal Cancer Screening Tests Market Size By Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]) Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Published Date: February 2020 | Publisher: Graphical Research Report ID: GR1288 | Delivery : PDF

Report Content

Chapter 1.     Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.   Data sources 

1.3.   References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.     Executive Summary

2.1.   European in-vitro colorectal cancer screening tests industry summay, 2015 - 2026

2.1.1.  Country trends

2.1.2.  Test type trends

Chapter 3.     Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2015 - 2026

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Growing adoption of screening tests for preventing bowel cancer

3.3.1.2.   Tehnological advancement in in-vitro colorectal cancer screening tests

3.3.1.3.   Increased incidence of colon and rectal cancer

3.3.2.  Restraints & challenges

3.3.2.1.   Fewer financial resources, resulting in disparities in screening

3.3.2.2.   Stringent government regulations for screening tests

3.4.   Regulatory landscape

3.4.1.  EU

3.5.   Technology landscape

3.6.   Porter’s analysis

3.7.   Competitive review, 2019

3.8.   PEST analysis

Chapter 4.         Europe In-vitro Colorectal Cancer Screening Tests Market, By Test Type

4.1.   Key trends in Europe in-vitro colorectal cancer screening tests, by test type

4.2.   Fecal occult blood test

4.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.2.  Guaiac FOB stool test

4.2.2.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.3.  Immuno-FOB agglutination test

4.2.3.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.4.  Lateral flow immuno-FOB test

4.2.4.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.5.  Immuno-FOB ELISA test

4.2.5.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.   Biomarker test

4.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.2.  Tumor M2-PK stool test

4.3.2.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.3.  Transferrin assays

4.3.3.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.   CRC DNA screening test

4.4.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.2.  Methylated gene test

4.4.2.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.3.  Panel DNA test

4.4.3.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

Chapter 5.         Europe In-vitro Colorectal Cancer Screening Tests, By Country

5.1.   Key trends in Europe in-vitro colorectal cancer screening tests, by country

5.2.   Germany

5.2.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.3.   UK

5.3.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.4.   France

5.4.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.5.   Italy

5.5.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.6.   Spain

5.6.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.7.   The Netherlands

5.7.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.8.   Denmark

5.8.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.9.   Russia

5.9.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.10.   Poland

5.10.1. Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.11.   Sweden

5.11.1. Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.12.   Norway

5.12.1. Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

Chapter 6.     Company Profiles

6.1.   Abbott Laboratories

6.1.1.  Business overview

6.1.2.  Financial data

6.1.3.  Product landscape

6.1.4.  Strategic outlook

6.2.   Beckman Coulter, Inc.

6.2.1.  Business overview

6.2.2.  Financial data

6.2.3.  Product landscape

6.2.4.  Strategic outlook

6.3.   EMD Millipore (Merck Group)

6.3.1.  Business overview

6.3.2.  Financial data

6.3.3.  Product landscape

6.3.4.  Strategic outlook

6.4.   Epigenomics AG Corporation

6.4.1.  Business overview

6.4.2.  Financial data

6.4.3.  Product landscape

6.4.4.  Strategic outlook

6.5.   Kyowa Kirin Co., Ltd. (Kyowa Medex Co., Ltd.)

6.5.1.  Business overview

6.5.2.  Financial data

6.5.3.  Product landscape

6.5.4.  Strategic outlook

6.6.   Novigenix SA

6.6.1.   Business overview

6.6.2.   Financial data

6.6.3.   Product landscape

6.6.4.   Strategic outlook

6.7.   Qiagen N.V.

6.7.1.   Business overview

6.7.2.   Financial data

6.7.3.   Product landscape

6.7.4.   Strategic outlook

6.8.   Quest Diagnostics

6.8.1.   Business overview

6.8.2.   Financial data

6.8.3.   Product landscape

6.8.4.   Strategic outlook

6.9.   Randox Laboratories Ltd.

6.9.1.   Business overview

6.9.2.   Financial data

6.9.3.   Product landscape

6.9.4.   Strategic outlook

6.10. R-Biopharm AG

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

6.11. Roche Molecular System, Inc.

6.11.1. Business overview

6.11.2. Financial data

6.11.3. Product landscape

6.11.4. Strategic outlook

6.12. Siemens Healthcare

6.12.1. Business overview

6.12.2. Financial data

6.12.3. Product landscape

6.12.4. Strategic outlook

6.13. Sysmex Corporation

6.13.1. Business overview

6.13.2. Financial data

6.13.3. Product landscape

6.13.4. Strategic outlook

Data Tables

TABLE 1.    Europe market estimates by country, (USD Mn), 2015 - 2019

TABLE 2.    Europe market forecast by country, (USD Mn), 2020 - 2026

TABLE 3.    Europe market estimates by test type, (USD Mn), 2015 - 2019

TABLE 4.    Europe market forecast by test type, (USD Mn), 2020 – 2026

TABLE 5.    Guideline for various patient group

TABLE 6.    Europe fecal occult blood test market estimates and forecast, by country, 2015 – 2026 (USD Mn)

TABLE 7.    Europe guaiac FOB stool test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 8.    Europe immuno-FOB agglutination test market esitmates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 9.    Europe lateral flow immuno-FOB test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 10.  Europe immuno-FOB ELISA test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 11.  Europe biomarker test market estimates and forecast, by country, 2015 – 2026 (USD Mn)

TABLE 12.  Europe tumor M2-PK stool test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 13.  Europe transferrin assays market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 14.  Europe CRC DNA screening test market estimates and forecast, by country, 2014 – 2026 (USD Mn)

TABLE 15.  Europe methylated gene test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 16.  Europe panel DNA test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 17.  Europe in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 18.  Europe in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 19.  Europe in-vitro colorectal cancer screening tests market estimates, by country (USD Mn), 2015 - 2019

TABLE 20.  Europe in-vitro colorectal cancer screening tests market forecast, by country (USD Mn), 2020 - 2026

TABLE 21.  Europe in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 22.  Europe in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 23.  Europe in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 24.  Europe in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 25.  Europe in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 26.  Europe in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 27.  Germany in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 28.  Germany in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 29.  Germany in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 30.  Germany in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 31.  Germany in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 32.  Germany in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 33.  Germany in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 34.  Germany in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 35.  Germany in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 36.  Germany in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 37.  UK in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 38.  UK in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 39.  UK in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 40.  UK in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 41.  UK in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 42.  UK in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 43.  UK in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 44.  UK in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 45.  UK in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 46.  UK in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 47.  France in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 48.  France in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 49.  France in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 50.  France in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 51.  France in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 52.  France in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 53.  France in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 54.  France in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 55.  France in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 56.  France in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 57.  Italy in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 58.  Italy in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 59.  Italy in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 60.  Italy in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 61.  Italy in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 62.  Italy in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 63.  Italy in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 64.  Italy in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 65.  Italy in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 66.  Italy in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 67.  Spain in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 68.  Spain in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 69.  Spain in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 70.  Spain in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 71.  Spain in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 72.  Spain in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 73.  Spain in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 74.  Spain in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 75.  Spain in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 76.  Spain in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 77.  The Netherlands in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 78.  The Netherlands in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 79.  The Netherlands in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 80.  The Netherlands in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 81.  The Netherlands in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 82.  The Netherlands in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 83.  The Netherlands in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 84.  The Netherlands in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 85.  The Netherlands in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 86.  The Netherlands in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 87.  Denmark in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 88.  Denmark in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 89.  Denmark in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 90.  Denmark in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 91.  Denmark in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 92.  Denmark in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 93.  Denmark in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 94.  Denmark in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 95.  Denmark in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 96.  Denmark in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 97.  Russia in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 98.  Russia in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 99.  Russia in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 100.      Russia in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 101.      Russia in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 102.      Russia in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 103.      Russia in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 104.      Russia in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 105.      Russia in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 106.      Russia in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 107.      Poland in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 108.      Poland in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 109.      Poland in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 110.      Poland in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 111.      Poland in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 112.      Poland in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 113.      Poland in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 114.      Poland in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 115.      Poland in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 116.      Poland in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 117.      Sweden in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 118.      Sweden in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 119.      Sweden in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 120.      Sweden in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 121.      Sweden in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 122.      Sweden in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 123.      Sweden in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 124.      Sweden in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 125.      Sweden in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 126.      Sweden in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 127.      Norway in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 128.      Norway in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 129.      Norway in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 130.      Norway in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 131.      Norway in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 132.      Norway in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 133.      Norway in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 134.      Norway in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 135.      Norway in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 136.      Norway in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

Charts & Figures

FIG 1.     Industry segmentation

FIG 2.     Europe in-vitro colorectal cancer screening tests industry outlook, 2015 - 2026

FIG 3.     Porter’s analysis

FIG 4.     PEST analysis


Select License

Europe In-vitro Colorectal Cancer Screening Tests Market 2026 | By Test type


Related Reports
Why Choose us?
  • On-Time Delivery
  • Assured Quality
  • Industry Experts
  • Payment Security
Share Social-media